Invention Grant
- Patent Title: Pharmaceutical composition
-
Application No.: US17106671Application Date: 2020-11-30
-
Publication No.: US11951103B2Publication Date: 2024-04-09
- Inventor: Hiroki Haniuda , Sachiko Enokizono , Tomoyuki Nakazato , Takuya Tokuda , Norie Fujiki
- Applicant: Kyowa Kirin Co., Ltd.
- Applicant Address: JP Tokyo
- Assignee: KYOWA KIRIN CO., LTD.
- Current Assignee: KYOWA KIRIN CO., LTD.
- Current Assignee Address: JP Tokyo
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP 16178599 2016.09.13
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; A61K9/00 ; A61K9/08 ; A61K47/02 ; A61K47/14 ; A61K47/38 ; A61K47/40
Abstract:
The present invention relates to a therapeutic agent for an ophthalmic disease comprising a vascular endothelial growth factor (VEGF) receptor inhibitor or an epidermal growth factor (EGF) receptor inhibitor in a nanoparticle form, having a property to be retained in a posterior eye tissue when systemically administered.
Public/Granted literature
- US20210077481A1 PHARMACEUTICAL COMPOSITION Public/Granted day:2021-03-18
Information query
IPC分类:
